AzurRx BioPharma begins trial of niclosamide tablets for Covid-19,

AzurRx BioPharma has started its Phase II clinical trial to evaluate micronised oral niclosamide tablets, known as FW-1022, in patients with Covid-19 …, AzurRx BioPharma has started its Phase II clinical trial to evaluate micronised oral niclosamide tablets, known as FW-1022, in patients with Covid-19 …, Read More

Scroll to Top